American Medical Association
FDANonrulemakingFDA-2021-N-0951

Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis; Public Workshop; Request for Comments

RIN
Last modified
Dec 6, 2021
Comment window
closed 1698d ago
American Medical Association filings
1

Activity

American Medical Association filed 1 comment on this docket between Dec 1, 2021 and Dec 1, 2021. 8 other organizations filed here. The comment window closed 1698d ago.

What American Medical Association filed (1)

Dec 1, 2021· Comment from American Medical Association· FDA-2021-N-0951-0032

Written remarks presented at FDA-Duke Margolis public workshop Oct. 14, 2021, by Bobby Mukkamala, MD, Chair, American Medical Association Board of Trustees on addressing the nation's drug overdose epidemic

Abstract

OPEN

View on regulations.gov →